REQUEST A DEMO
Total
USD $0.00
Search more companies

Reyon Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Reyon Pharmaceutical Co.,Ltd. Profile Updated: January 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

REYON Pharmaceutical Co., Ltd is a global bio & chemical pharmaceutical company. The company specializes in the production of APIs, finished drug products, and advanced biopharmaceuticals, including gene therapy, antibody therapy, cell therapy, and natural medicine. REYON is recognized for its know-how in synthesis and fermentation technology and is committed to supplying pharmaceutical products to customers. The company has a focus on expanding its CDMO business through business cooperation with various biotech companies. With over 65 years of experience in the pharmaceutical industry, REYON aims to innovate the pharmaceutical industry of the future.

Headquarters
38-6 Dongbinggo-Dong, Yongsan-Gu
Seoul; Seoul; Postal Code: 100-833

Contact Details: Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.

Website: http://reyonpharm.co.kr

Basic Information
Total Employees:
Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Reyon Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
November 25, 1964
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
41.36%
Purchase this report to view the information.
10.4%
Purchase this report to view the information.
7.75%
Purchase this report to view the information.
6.26%
Purchase this report to view the information.
3.88%
Subsidiaries
리온즈신약연구소(주)
브라만투자조합1호
아르케인베스트먼트(주)
Company Performance
Financial values in the chart are available after Reyon Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
0.94%
Total Operating Revenue
2.91%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
-4.4%
Total Equity
-5.77%
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
29862%
Quick Ratio
-5.26%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?